co-and posttranslational folding, chaperones are reThe mutation is inherited in an autosomal dominant quired for the translocation of many proteins across manner, and the same mutational mechanism is responcellular membranes, are involved in macromolecular assible for a growing number of less common neurodegensembly and disassembly, and facilitate the transfer of erative disorders that include the spinocerebellar ataxmisfolded proteins to the proteasome for degradation. ias (SCAs). AD, PD, and HD each display characteristic Many chaperones are also components of signal transpatterns of neuronal cell loss and behavioral phenoduction cascades that mediate transcriptional retypes. In AD, cell loss is most prominent in the neocortex sponses to stress, including those that lead to the supand hippocampus, and is accompanied by memory loss, pression of apoptosis. Chaperones function by binding dementia, and impairment in other forms of cognition transiently to exposed hydrophobic surfaces in target and behavior. PD is characterized by a loss of dopaminproteins in a manner that is regulated by ATP-induced ergic neurons in the substantia nigra and is accompaconformational changes that occur in their substrate nied by muscle rigidity, bradykinesia, and resting tremor. 
that dissociates aggregation of polyQ-containing proThese toxic soluble forms (see below) are presumably teins (judged at the level of light microscopy) from toxicdistinct from the "amorphous," detergent-soluble forms ity (reviewed by Zoghbi and Orr, 2000). In light of results that one would predict might be increased by chaperone that highlight the toxic nature of protofibrils, and based treatment in models of AD.
on the known affinity of chaperones for folding intermeChaperones are one of the best examples of multidiates, it is tempting to speculate that chaperones profunctional proteins, and their protection against neurotect against neurodegeneration in animal models by actdegeneration may result from one or more of their activiing at the level of protofibrils. It might be argued that ties in cells, perhaps in addition to their ability to inhibit by binding to protofibrils, chaperones induce a conforfibril formation directly. In one recent study, the Hsp70/ mational change that leads to the generation of amorHsp40 chaperone system was shown not only to enphous, nontoxic aggregates, which at the same time hance the solubility of expanded polyQ proteins, but to also decreases the cellular concentration of mature amalso increase the degradation of these proteins through yloid fibrils. the 26S proteasome (Bailey et al., 2002) . The increase Future Directions in polyQ solubility was accompanied by a 40% decrease While it is becoming clear that chaperones can have a in the half-life of the expanded polyQ proteins. This profound influence on solubility, aggregation, fibril forimportant result indicates that an excess of chaperone mation, and toxicity of proteins that misfold and cause capacity in the cell can shift the equilibrium between neurodegenerative disorders, many issues remain to be amorphous (detergent-soluble) and fibrillar (detergentexamined. The disease-causing proteins associated insoluble) aggregates such that the cell's proteolytic with AD, PD, and HD can apparently misfold into multiple machinery can more efficiently turn over the toxic polyQ toxic conformations and pre-fibrillar intermediates with proteins. Nevertheless, the mechanism chaperones use different morphologies. However, the structural nature to facilitate clearance of misfolded proteins by the proand, just as importantly, downstream targets of these teasome remains to be elucidated, and may indicate a intermediates remain uncharacterized and will need to be elucidated if they are to be pursued as drug targets. useful target for pharmacological intervention. A role for Chaperones may protect against neurodegenerative progression and severity in patients with neurodegenerative disorders. disorders in animal models by acting at one or more steps in the pathway of fibril formation (Figure 1) . ChapIn summary, recent studies suggest that chaperones may play a critical role in neurodegeneration and aging, erones may convert toxic conformations of misfolded proteins to nontoxic forms that can be tolerated by cells, and this class of proteins holds much promise as a therapeutic target for the treatment of neurodegeneraalthough direct biophysical evidence for this hypothesis is lacking. Chaperones may also prevent the formation tive disorders. While the identification of small molecules that can enhance chaperone expression or activiof toxic pre-fibrillar intermediates, or accelerate their conversion to nontoxic amorphous aggregates that can ties in brain cells may seem like a daunting task, it is worthy to note that a small molecule antagonist of the be turned over more easily by the proteolytic machinery. Although evidence indicates that chaperones act on chaperone Hsp90 is currently in clinical trials for the treatment of recurrent, refractory breast cancer (Bagapre-fibrillar intermediates and not mature fibrils (Muchowski et al., 2000) , the molecular basis of these intertell et al., 2001). actions is not known and should be resolved.
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